Viewing Study NCT06793956


Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2026-01-01 @ 8:04 PM
Study NCT ID: NCT06793956
Status: RECRUITING
Last Update Posted: 2025-03-13
First Post: 2025-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sintilimab and Linperlisib Combination Treatment in Relapsed or Refractory Extranodal Natural Killer/T Cell Lymphoma
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module